John Winters from Superhero.com.au talks about the pros and cons of investing in AI companies like Anthropic and Nvidia.

John Winters from Superhero.com.au talks about the pros and cons of investing in AI companies like Anthropic and Nvidia.

Money News — the most respected business program on radio.

If you crave the latest insights into super & small business, interest rates & investment, and economics & e-commerce, then the team at Money News has everything you need to know.

Add your voice to the conversation Monday to Thursday 7pm to 8pm by calling 131 873, texting 0460 873 873, or emailing moneynews@2gb.com

Money News &mdash; the most respected business program on radio.
If you crave the latest insights into super &amp; small business, interest rates &amp; investment, and economics &amp; e-commerce, then the team at Money News has everything you need to know.
Add your voice to the conversation Monday to Thursday 7pm to 8pm by calling 131 873, texting 0460 873 873, or emailing <a href="mailto:moneynews@2gb.com">moneynews@2gb.com</a>

Money News

Money News - Highlights

Audio highlights from Sydney's number one station.

Audio highlights from Sydney's number one station.

2GB On-Demand

Investing in AI

This is your week in Money News, with Clinton Maynard.

Heather Macilvane on David Jones 
John McGrath on Real Estate
Catherine King on Career Coach 
Roger Montgomery on Productivity
Jane Hume on Red Tape
Joel Harty on ETFs
Michael Brennan on Bracket Creep

This is your week in Money News, with Clinton Maynard. Heather Macilvane on David Jones&nbsp; John McGrath on Real Estate Catherine King on Career Coach&nbsp; Roger Montgomery on Productivity Jane Hume on Red Tape Joel Harty on ETFs Michael Brennan on Bracket Creep

MONEY WEEK with Clinton Maynard - Friday 13 November

Clinton Maynard toalks to Rebekah Cassidy from Ausbiotech about the proposed 15-year cap on the R&D Tax Incentive ignores the lengthy clinical trial timelines needed for complex diseases like cancer and dementia, threatening to drive vital research, manufacturing, and investment offshore.  

Clinton Maynard toalks to Rebekah Cassidy from Ausbiotech about the proposed 15-year cap on the R&amp;D Tax Incentive ignores the lengthy clinical trial timelines needed for complex diseases like cancer and dementia, threatening to drive vital research, manufacturing, and investment offshore.&nbsp;&nbsp;

Will Biotech Research go Offshore?

Renowned fund manager Roger Montgomery unpacks the structural challenges holding back Australian productivity and what they mean for long-term economic growth

Renowned fund manager Roger Montgomery unpacks the structural challenges holding back Australian productivity and what they mean for long-term economic growth

Investing in AI

In 3 playlist(s)

Money News

Social links

Follow podcast

Recent clips